Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Human Cells
1.2.3 Microbial Cells
1.2.4 Animal Cells
1.3 Market by Application
1.3.1 Global Cell Viability Assays Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutes
1.3.4 Hospital and Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Viability Assays Market Perspective (2018-2033)
2.2 Cell Viability Assays Growth Trends by Region
2.2.1 Global Cell Viability Assays Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell Viability Assays Historic Market Size by Region (2018-2023)
2.2.3 Cell Viability Assays Forecasted Market Size by Region (2024-2033)
2.3 Cell Viability Assays Market Dynamics
2.3.1 Cell Viability Assays Industry Trends
2.3.2 Cell Viability Assays Market Drivers
2.3.3 Cell Viability Assays Market Challenges
2.3.4 Cell Viability Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Viability Assays Players by Revenue
3.1.1 Global Top Cell Viability Assays Players by Revenue (2018-2023)
3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2018-2023)
3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Viability Assays Revenue
3.4 Global Cell Viability Assays Market Concentration Ratio
3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2022
3.5 Cell Viability Assays Key Players Head office and Area Served
3.6 Key Players Cell Viability Assays Product Solution and Service
3.7 Date of Enter into Cell Viability Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Viability Assays Breakdown Data by Type
4.1 Global Cell Viability Assays Historic Market Size by Type (2018-2023)
4.2 Global Cell Viability Assays Forecasted Market Size by Type (2024-2033)
5 Cell Viability Assays Breakdown Data by Application
5.1 Global Cell Viability Assays Historic Market Size by Application (2018-2023)
5.2 Global Cell Viability Assays Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell Viability Assays Market Size (2018-2033)
6.2 North America Cell Viability Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cell Viability Assays Market Size by Country (2018-2023)
6.4 North America Cell Viability Assays Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Viability Assays Market Size (2018-2033)
7.2 Europe Cell Viability Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cell Viability Assays Market Size by Country (2018-2023)
7.4 Europe Cell Viability Assays Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Viability Assays Market Size (2018-2033)
8.2 Asia-Pacific Cell Viability Assays Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cell Viability Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Viability Assays Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Viability Assays Market Size (2018-2033)
9.2 Latin America Cell Viability Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cell Viability Assays Market Size by Country (2018-2023)
9.4 Latin America Cell Viability Assays Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Viability Assays Market Size (2018-2033)
10.2 Middle East & Africa Cell Viability Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cell Viability Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Viability Assays Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Cell Viability Assays Introduction
11.2.4 Merck Revenue in Cell Viability Assays Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Cell Viability Assays Introduction
11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 GE
11.4.1 GE Company Detail
11.4.2 GE Business Overview
11.4.3 GE Cell Viability Assays Introduction
11.4.4 GE Revenue in Cell Viability Assays Business (2018-2023)
11.4.5 GE Recent Development
11.5 Danaher
11.5.1 Danaher Company Detail
11.5.2 Danaher Business Overview
11.5.3 Danaher Cell Viability Assays Introduction
11.5.4 Danaher Revenue in Cell Viability Assays Business (2018-2023)
11.5.5 Danaher Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Cell Viability Assays Introduction
11.6.4 BD Revenue in Cell Viability Assays Business (2018-2023)
11.6.5 BD Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Detail
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Cell Viability Assays Introduction
11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2018-2023)
11.7.5 PerkinElmer Recent Development
11.8 Promega
11.8.1 Promega Company Detail
11.8.2 Promega Business Overview
11.8.3 Promega Cell Viability Assays Introduction
11.8.4 Promega Revenue in Cell Viability Assays Business (2018-2023)
11.8.5 Promega Recent Development
11.9 Biotium
11.9.1 Biotium Company Detail
11.9.2 Biotium Business Overview
11.9.3 Biotium Cell Viability Assays Introduction
11.9.4 Biotium Revenue in Cell Viability Assays Business (2018-2023)
11.9.5 Biotium Recent Development
11.10 Abcam
11.10.1 Abcam Company Detail
11.10.2 Abcam Business Overview
11.10.3 Abcam Cell Viability Assays Introduction
11.10.4 Abcam Revenue in Cell Viability Assays Business (2018-2023)
11.10.5 Abcam Recent Development
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Detail
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Cell Viability Assays Introduction
11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2018-2023)
11.11.5 Creative Bioarray Recent Development
11.12 Biotek Instruments
11.12.1 Biotek Instruments Company Detail
11.12.2 Biotek Instruments Business Overview
11.12.3 Biotek Instruments Cell Viability Assays Introduction
11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2018-2023)
11.12.5 Biotek Instruments Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Human Cells
Table 3. Key Players of Microbial Cells
Table 4. Key Players of Animal Cells
Table 5. Global Cell Viability Assays Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cell Viability Assays Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cell Viability Assays Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cell Viability Assays Market Share by Region (2018-2023)
Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Cell Viability Assays Market Share by Region (2024-2033)
Table 11. Cell Viability Assays Market Trends
Table 12. Cell Viability Assays Market Drivers
Table 13. Cell Viability Assays Market Challenges
Table 14. Cell Viability Assays Market Restraints
Table 15. Global Cell Viability Assays Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cell Viability Assays Market Share by Players (2018-2023)
Table 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)
Table 18. Ranking of Global Top Cell Viability Assays Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell Viability Assays Product Solution and Service
Table 22. Date of Enter into Cell Viability Assays Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cell Viability Assays Revenue Market Share by Type (2018-2023)
Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Cell Viability Assays Revenue Market Share by Type (2024-2033)
Table 28. Global Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cell Viability Assays Revenue Market Share by Application (2018-2023)
Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Cell Viability Assays Revenue Market Share by Application (2024-2033)
Table 32. North America Cell Viability Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cell Viability Assays Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Cell Viability Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cell Viability Assays Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Cell Viability Assays Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Cell Viability Assays Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cell Viability Assays Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Cell Viability Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cell Viability Assays Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Cell Viability Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cell Viability Assays Market Size by Country (2024-2033) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Cell Viability Assays Product
Table 50. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Cell Viability Assays Product
Table 55. Merck Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Bio-Rad Company Detail
Table 58. Bio-Rad Business Overview
Table 59. Bio-Rad Cell Viability Assays Product
Table 60. Bio-Rad Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 61. Bio-Rad Recent Development
Table 62. GE Company Detail
Table 63. GE Business Overview
Table 64. GE Cell Viability Assays Product
Table 65. GE Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 66. GE Recent Development
Table 67. Danaher Company Detail
Table 68. Danaher Business Overview
Table 69. Danaher Cell Viability Assays Product
Table 70. Danaher Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 71. Danaher Recent Development
Table 72. BD Company Detail
Table 73. BD Business Overview
Table 74. BD Cell Viability Assays Product
Table 75. BD Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 76. BD Recent Development
Table 77. PerkinElmer Company Detail
Table 78. PerkinElmer Business Overview
Table 79. PerkinElmer Cell Viability Assays Product
Table 80. PerkinElmer Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 81. PerkinElmer Recent Development
Table 82. Promega Company Detail
Table 83. Promega Business Overview
Table 84. Promega Cell Viability Assays Product
Table 85. Promega Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 86. Promega Recent Development
Table 87. Biotium Company Detail
Table 88. Biotium Business Overview
Table 89. Biotium Cell Viability Assays Product
Table 90. Biotium Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 91. Biotium Recent Development
Table 92. Abcam Company Detail
Table 93. Abcam Business Overview
Table 94. Abcam Cell Viability Assays Product
Table 95. Abcam Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 96. Abcam Recent Development
Table 97. Creative Bioarray Company Detail
Table 98. Creative Bioarray Business Overview
Table 99. Creative Bioarray Cell Viability Assays Product
Table 100. Creative Bioarray Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 101. Creative Bioarray Recent Development
Table 102. Biotek Instruments Company Detail
Table 103. Biotek Instruments Business Overview
Table 104. Biotek Instruments Cell Viability Assays Product
Table 105. Biotek Instruments Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
Table 106. Biotek Instruments Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Viability Assays Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cell Viability Assays Market Share by Type: 2022 VS 2033
Figure 3. Human Cells Features
Figure 4. Microbial Cells Features
Figure 5. Animal Cells Features
Figure 6. Global Cell Viability Assays Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Cell Viability Assays Market Share by Application: 2022 VS 2033
Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
Figure 9. Academic and Research Institutes Case Studies
Figure 10. Hospital and Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Cell Viability Assays Report Years Considered
Figure 13. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Cell Viability Assays Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Cell Viability Assays Market Share by Region: 2022 VS 2033
Figure 16. Global Cell Viability Assays Market Share by Players in 2022
Figure 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2022
Figure 19. North America Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Cell Viability Assays Market Share by Country (2018-2033)
Figure 21. United States Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cell Viability Assays Market Share by Country (2018-2033)
Figure 25. Germany Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Cell Viability Assays Market Share by Region (2018-2033)
Figure 33. China Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Cell Viability Assays Market Share by Country (2018-2033)
Figure 41. Mexico Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Cell Viability Assays Market Share by Country (2018-2033)
Figure 45. Turkey Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 49. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 50. GE Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 51. Danaher Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 52. BD Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 53. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 54. Promega Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 55. Biotium Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 56. Abcam Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 57. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 58. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed